Bottom line
Is VUSV a good fund? The bottom line
VUSV is a managed allocation / balanced ETF from Vanguard.
Annual fees run 0.3% — about $30 a year on every $10,000 invested, cheaper than 95% of allocation / balanced funds we track.
With $74.4 million in net assets and 86 holdings, its largest position is Alphabet Inc (3.0%) and the top 10 make up 23.6% of the portfolio.
What stands out
- Low cost: cheaper than 95% of allocation / balanced peers
Updated Nov 19, 2026
What VUSV invests in
Vanguard Wellington U.S. Value Active ETF (the Fund) seeks to provide long-term capital appreciation.
The Fund employs an active management approach, investing primarily in large- and mid-capitalization companies whose stocks are considered by the Funds advisor to be undervalued. Undervalued stocks are generally those that are out of favor with investors and that the advisor believes are trading at prices that are below average in relation to measures such as earnings and book value. Under normal circumstances, the Fund invests at least 80% of its net assets, plus the amount of any borrowings for investment purposes, in U.S. securities. For the purposes of the 80% policy, a U.S. security is any security that is issued by a U.S. company.
From the fund's prospectus (filed Jan 28, 2026).
What VUSV costs
On a $10,000 investment, VUSV's 0.3% expense ratio costs about $30 a year. The median allocation / balanced fund charges 0.91%.
VUSV top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Alphabet Inc | 3.05% |
| 2 | Amazon.com Inc | 3.04% |
| 3 | Microsoft Corp | 2.61% |
| 4 | Merck & Co Inc | 2.57% |
| 5 | ASML Holding NV | 2.55% |
| 6 | Chubb Ltd | 2.13% |
| 7 | Vanguard Cmt Funds-Vanguard Market Liquidity Fund | 2.07% |
| 8 | Morgan Stanley | 1.95% |
| 9 | UnitedHealth Group Inc | 1.85% |
| 10 | SLB Ltd | 1.81% |
Source: SEC Form N-PORT, period ended Jun 30, 2026
The top 10 make up 23.6% of the fund. See all top 25 holdings and asset mix →